TTY Biopharm Company Limited (4105.TWO) Key Statistics
$80.10TWO: 4105.TWOMarket Cap $20.04B
Every valuation, profitability, balance-sheet and per-share figure DeltaScreener holds for TTY Biopharm Company Limited (4105.TWO), each with what it measures. Figures are trailing twelve months or the most recent reported period.
Valuation
Metric
Value
P/E ratioShare price divided by earnings per share.
11.58
P/B ratioShare price divided by book value per share.
2.88
P/S ratioMarket value divided by annual revenue.
3.01
PEG ratioP/E divided by the earnings growth rate.
0.27
EV / EBITDAEnterprise value against earnings before interest, tax, depreciation and amortisation.
9.70
EV / RevenueEnterprise value against annual revenue.
3.00
Earnings yieldEarnings per share as a percentage of the share price — the inverse of P/E.
8.64%
Profitability
Metric
Value
Gross marginRevenue left after the direct cost of goods sold.
57.57%
Operating marginRevenue left after operating costs.
29.49%
Net marginRevenue left after every cost, including tax and interest.
26.04%
Return on equityProfit as a percentage of shareholders’ equity.
25.11%
Return on assetsProfit as a percentage of total assets.
10.35%
Financial health
Metric
Value
Current ratioCurrent assets divided by current liabilities. Above 1 means short-term assets cover short-term bills.
2.13
Quick ratioThe same, excluding inventory.
1.47
Debt to equityTotal borrowings against shareholders’ equity.
0.27
Per share and size
Metric
Value
Earnings per shareProfit attributable to each share.
$6.96
Book value per shareShareholders’ equity divided by shares outstanding.
$27.97
Shares outstandingShares currently issued.
248,649,959
Market capitalisationShare price times shares outstanding.
$20.04B
Enterprise valueMarket value plus net debt — what it would cost to buy the business outright.
$0
Dividend
Metric
Value
Dividend yieldAnnual dividend as a percentage of the share price.
5.54%
Payout ratioShare of profit paid out as dividends.
64.15%
TTY Biopharm Company Limited (4105.TWO) statistics — frequently asked questions
What is TTY Biopharm Company Limited's P/E ratio?
TTY Biopharm Company Limited (4105.TWO) trades on a price-to-earnings ratio of 11.58.
What is TTY Biopharm Company Limited's return on equity?
TTY Biopharm Company Limited (4105.TWO) reports a return on equity of 25.11%, meaning it generated that much profit for every dollar of shareholders' equity.
How much debt does TTY Biopharm Company Limited carry?
TTY Biopharm Company Limited (4105.TWO) has a debt-to-equity ratio of 0.27, which compares total borrowings with shareholders' equity.
What is TTY Biopharm Company Limited's profit margin?
TTY Biopharm Company Limited (4105.TWO) keeps 26.04% of revenue as net profit after every cost, including tax and interest.